Awaiting development: Guidance and quality standards
Showing 1 to 1 of 1
| Title | Type |
|---|---|
| Ravulizumab for preventing kidney events in people with chronic kidney disease at high risk after a cardiopulmonary bypass [ID6632] | Technology appraisal guidance |
| Title | Type |
|---|---|
| Ravulizumab for preventing kidney events in people with chronic kidney disease at high risk after a cardiopulmonary bypass [ID6632] | Technology appraisal guidance |